Southampton, United Kingdom

Stephen Beers

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 7.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Stephen Beers

Introduction

Stephen Beers is a notable inventor based in Southampton, GB. He has made significant contributions to the field of immunology, particularly in the development of antibody-based therapies. With a total of 4 patents to his name, Beers has focused on innovative methods for treating cancer.

Latest Patents

Among his latest patents, one describes the combination and use of antibodies. This invention involves a first antibody molecule that specifically binds to FcγRIIb via its Fab region, while lacking the Fc region or having reduced binding to Fcγ receptors. This first antibody is used in combination with a second antibody molecule that binds to a receptor on an immune cell, which suppresses anti-cancer immunity. The second antibody has an Fc region that binds to at least one activating Fcγ receptor. The binding of this second antibody to the immune cell receptor leads to the depletion or deactivation of the immune cell, aiding in the treatment of FcγRIIb-negative cancers in patients. Additionally, he has developed pharmaceutical compositions and kits that incorporate these antibody molecules, along with methods for treating cancer using both antibodies.

Another significant patent involves the combined use of FcγRIIb (CD32B) and CD20 specific antibodies. This invention provides a method for treating patients with target cells that express FcγRIIb. The method includes administering an antibody molecule that specifically binds to a surface antigen of the target cell, which has an Fc domain capable of binding FcγRIIb. This is combined with an agent that prevents or reduces the binding between the Fc domain and FcγRIIb. The patients are selected based on the elevated levels of FcγRIIb expressed by their target cells.

Career Highlights

Stephen Beers has worked with prominent organizations such as the University of Southampton and Cancer Research Technology Limited. His work has significantly advanced the understanding and treatment of cancer through innovative antibody therapies.

Collaborations

Some of his notable coworkers include Ingrid Teige and Mark Steven Cragg. Their collaborative efforts have contributed to the success of his research and inventions.

Conclusion

Stephen Beers is a distinguished inventor whose work in antibody-based therapies has the potential to transform cancer treatment. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…